Skip to main content

and
  1. Article

    Open Access

    Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy

    The multifaceted chemo-immune resistance is the principal barrier to achieving cure in cancer patients. Identifying a target that is critically involved in chemo-immune-resistance represents an attractive stra...

    Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang in Nature Communications (2024)